Profiles of Medicinal Cannabis Patients Attending Compassion Centers in Rhode Island

Journal of Psychoactive Drugs

Volumn 47, Issue 1, 2015, Pages 18-23

  Zaller, Nickolas ^a   Topletz, Ariel ^b   Frater, Susan ^b   Yates, Gail ^b   Lally, Michelle ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

cannabis; chronic pain; Compassion Center; Rhode Island

Indexed keywords

MEDICAL CANNABIS;

ADOLESCENT; ADULT; AGED; ALCOHOL USE DISORDER; ANALGESIA; ARTICLE; BRIEF PAIN INVENTORY; CHILD; CHRONIC PAIN; CO-OCCURRING DISORDERS SCREENING INSTRUMENT DISORDERS FOR MENTAL DISORDERS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG USE; DSM-IV; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH INSURANCE; HUMAN; INCOME; MALE; PAIN SEVERITY; PRESCRIPTION; SELF REPORT; SHORT SURVEY; SMOKING; HEALTH CENTER; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROCEDURES; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ADULT; COMMUNITY HEALTH CENTERS; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEMALE; HUMANS; MALE; MEDICAL MARIJUANA; MIDDLE AGED; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; RHODE ISLAND; SELF REPORT; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84924174879     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2014.999901     Document Type: Article

References (22)

1. Abrams, D.I.; Couey, P.; Shade, S.B.; Kelly, M.E. & Benowitz, N.L. 2011. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther 90 (6): 844–51.
2. Bachhuber, M.A.; Saloner, B.; Cunningham, C.O. & Barry, C.L. 2014. Medical cannabis laws and opioid analgesic oversode mortality in the United States, 1999–2010. JAMA Intern Med 174 (10): 1668–73. 2014.
3. Ben Amar, M. 2006. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 105 (1–2): 1–25.
4. Bonn-Miller, M.O.; Boden, M.T.; Bucossi, M.M. & Babson, K.A. 2014. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse 40 (1): 23–30.
5. Bottorff, J.L.; Bissell, L.J.; Balneaves, L.G.; Oliffe, J.L.; Capler, N.R. & Buxton, J. 2013. Perceptions of cannabis as a stigmatized medicine: A qualitative descriptive study. Harm Reduct J 10: 2.
6. Carter, G.T.; Flanagan, A.M.; Earleywine, M.; Abrams, D.I.; Aggarwal, S.K. & Grinspoon, L. 2011. Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care 28 (5): 297–303.
7. Hazekamp, A.; Ware, M.A.; Muller-Vahl, K.R.; Abrams, D. & Grotenhermen, F. 2013. The medicinal use of cannabis and cannabinoids: An international cross-sectional survey on administration forms. J Psychoactive Drugs 45 (3): 199–210.
8. Ilgen, M.A.; Bohnert, K.; Kleinberg, F.; Jannausch, M.; Bohnert, A.S.; Walton, M. & Blow, F.C. 2013. Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend 132 (3): 654–9.
9. Johnson, J.R.; Lossignol, D.; Burnell-Nugent, M. & Fallon, M.T. 2013. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage 46 (2): 207–18.
10. Koppel, B.S.; Brust, J.C.; Fife, T.; Bronstein, J.; Youssof, S.; Gronseth, G. & Gloss, D. 2014. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82 (17): 1556–63.
11. Nunberg, H.; Kilmer, B.; Pacula, R.L. & Burgdorf, J. 2011. An analysis of applicants presenting to a medical marijuana specialty practice in California. J Drug Policy Anal 4 (1): 1–9.
12. Pain Management of Rhode Island. 2014 Rhode Island Medical Marijuana Act Available at: http://rhode-island.medicalmarijuana.net/
13. Rahn, E.J. & Hohmann, A.G. 2009. Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside. Neurotherapeutics 6 (4): 713–37.
14. Reinarman, C.; Nunberg, H.; Lanthier, F. & Heddleston, T. 2011. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs 43 (2): 128–35.
15. Rhode Island Patient Advocacy Coalition (RIPAC). 2013. Current Status of Compassion Centers in Rhode Island Available at: http://ripatients.org/compassioncenters.html
16. Riskcowski, J.R. 2014. Associations of socioeconomic position and pain prevalence in the United States: Findings from the National Health and Nutrition Examination Survey. Pain Medicine 15 (9): 1508–21.
17. Sacks, S.; Melnick, G.; Coen, C.; Banks, S.; Friedmann, P.D.; Grella, C.; Knight, K. & Zlotnick, C. 2007. CJDATS co-occurring disorders screening instrument (CODSI) for mental disorders (MD): A validation Study. Crim Justice Behav 34 (9): 1198–1216.
18. Shi, Q.; Wang, X.S.; Mendoza, T.R.; Pandya, K.J. & Cleeland, C.S. 2009. Assessing persistent cancer pain: A comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage 37 (2): 168–74.
19. State of Rhode Island Department of Health (Health). 2013 Fatal drug overdoses. Available at: http://www.health.ri.gov/data/death/drugoverdoses/
20. Subbaraman, M.S. 2013. Can cannabis be considered a substitute medication for alcohol? Alcohol Alcohol. 49 (3): 292–98.
21. Ware, M.A.; Wang, T.; Shapiro, S.; Robinson, A.; Ducruet, T.; Huynh, T.; Gamsa, A.; Bennett, G.J. & Collet, J.P. 2010. Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. CMAJ 182 (14): E694–701.
22. Yokell, M.A.; Green, T.C.; Bowman, S.; McKenzie, M. & Rich, J.D. 2011. Opioid overdose prevention and naloxone distribution in Rhode Island. Med Health R I 94 (8): 240–2.